Under Leukaemia section from NICE Technology Appraisal Guideline published on April 2012
Leukaemia (chronic myeloid, first line) - dasatinib, nilotinib and standard-dose imatinib
Docplexus Admin
Medical Writer
Join the community and view the full post,
write comments and share this post.
🩺 India's Largest Platform for Doctors
✅ 5,10,000+ Verified Doctors
💬 60,000+ Clinical Discussions